Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing facilities in Gebze to Generica İlaç, a Turkish company engaged in the manufacturing, marketing and sale of pharmaceutical products since 2007. The transaction includes the transfer of all associated assets and employees of Sandoz Turkey on the Gebze site. The deal is expected to close by mid-2020 subject to obtaining the necessary approvals from regulatory authorities, including the Competition Board, the Gebze Plastic Manufacturers Organized Industrial Zone and the Ministry of Industry and Technology. After closing, Generica İlaç will continue to manufacture and supply certain products to Novartis.
Paksoy is pleased to announce that Elvan Aziz (partner), Nazlı Bezirci (counsel) and Gözde Zorlu (associate) are advising Novartis on this transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
17 September 2025
Paksoy advises Ege Kimya on its recent acquisitions of Venator Materials’ Driers Book of Business and 100% of the shares in Metal Oksit Kimya Sanayii A.Ş.
Ege Kimya is a leading Turkish chemicals company with operations in intermediate chemicals serving both domestic and international markets.…
9 September 2025
Paksoy advises Parsan, a Güriş Holding company listed on Borsa Istanbul, on the merger with Omtaş
Parsan, a Güriş Holding group company listed on Borsa Istanbul and active in integrated steel forging and machining business, has now…
4 September 2025
Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher
Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…
25 August 2025
Paksoy advised Paribu on acquisition of Boxbilet
Paribu, a leading cryptocurrency platform in Türkiye, has acquired 100% of Boxbilet, the developer of BoxSale and Bonus Parkorman mobile…
9 July 2025
We are proud to maintain our leading position in Türkiye’s M&A market
Mergermarket 2025 H1 EMEA Legal Advisory Rankings Announced
3 July 2025
Paksoy advised International Finance Corporation (IFC) on its investment in USD 100 million issuance of Digitally Native Notes by Türkiye İş Bankası A.Ş.
We have acted as legal advisor to IFC on its investment in Türkiye İş Bankası A.Ş.’s inaugural issuance of USD 100 million Floating Rate…